510 related articles for article (PubMed ID: 8105101)
1. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
[TBL] [Abstract][Full Text] [Related]
2. Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine.
Herweijer H; Sonneveld P; Baas F; Nooter K
J Natl Cancer Inst; 1990 Jul; 82(13):1133-40. PubMed ID: 1972761
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and northern blot analysis.
Wulf G; Kluding H; Ho AD; Doerner M; Doehner H; Manegold C; Hunstein W
Leuk Res; 1994 Jul; 18(7):475-84. PubMed ID: 7912754
[TBL] [Abstract][Full Text] [Related]
4. [Functional detection of P-glycoprotein expressing cells with flow cytometry].
Ludescher C; Hilbe W; Eisterer W; Preuss E; Hofmann J; Thaler J
Wien Klin Wochenschr; 1994; 106(8):242-6. PubMed ID: 7912868
[TBL] [Abstract][Full Text] [Related]
5. High expression of the mdr3 multidrug-resistance gene in advanced-stage chronic lymphocytic leukemia.
Sonneveld P; Nooter K; Burghouts JT; Herweijer H; Adriaansen HJ; van Dongen JJ
Blood; 1992 Mar; 79(6):1496-500. PubMed ID: 1347708
[TBL] [Abstract][Full Text] [Related]
6. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs.
Chaudhary PM; Roninson IB
J Natl Cancer Inst; 1993 Apr; 85(8):632-9. PubMed ID: 8096875
[TBL] [Abstract][Full Text] [Related]
7. Differences in rhodamine-123 efflux in B-type chronic lymphocytic leukemia suggest possible gender and stage variations in drug-resistance gene activity.
Steiner H; Polliack A; Kimchi-Sarfaty C; Libster D; Fibach E; Rund D
Ann Hematol; 1998 May; 76(5):189-94. PubMed ID: 9671131
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein expression and function in circulating blood cells from normal volunteers.
Klimecki WT; Futscher BW; Grogan TM; Dalton WS
Blood; 1994 May; 83(9):2451-8. PubMed ID: 7513198
[TBL] [Abstract][Full Text] [Related]
9. Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123.
Ludescher C; Thaler J; Drach D; Drach J; Spitaler M; Gattringer C; Huber H; Hofmann J
Br J Haematol; 1992 Sep; 82(1):161-8. PubMed ID: 1358171
[TBL] [Abstract][Full Text] [Related]
10. Chemomodulation of drugs involved in multidrug resistance in chronic lymphatic leukemia of the B-cell type.
Reichle A; Diddens H; Altmayr F; Rastetter J; Andreesen R
Cancer Chemother Pharmacol; 1994; 34(4):307-16. PubMed ID: 7913420
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance in B-cell chronic lymphocytic leukemia.
Grulois I; Fardel O; Drenou B; Lamy T; Le Prisé PY; Fauchet R
Acta Haematol; 1995; 94(2):78-83. PubMed ID: 7484017
[TBL] [Abstract][Full Text] [Related]
12. [Flow cytometric analysis of P-glycoprotein function by rhodamine 123 dye-efflux assay in human leukemia cells].
Kawabata M; Kobayashi H; Mori S; Sekiguchi S; Takemura Y
Rinsho Byori; 1997 Sep; 45(9):891-8. PubMed ID: 9311264
[TBL] [Abstract][Full Text] [Related]
13. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.
Yamaguchi M; Kita K; Miwa H; Nishii K; Oka K; Ohno T; Shirakawa S; Fukumoto M
Cancer; 1995 Dec; 76(11):2351-6. PubMed ID: 8635042
[TBL] [Abstract][Full Text] [Related]
14. Staining with Hoechst 33342 and rhodamine 123: an attempt to detect multidrug resistant phenotype cells in leukemia.
Lahmy S; Lautier D; Canitrot Y; Laurent G; Salmon JM
Leuk Res; 1993 Dec; 17(12):1021-9. PubMed ID: 7902473
[TBL] [Abstract][Full Text] [Related]
15. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
Leith CP; Kopecky KJ; Chen IM; Eijdems L; Slovak ML; McConnell TS; Head DR; Weick J; Grever MR; Appelbaum FR; Willman CL
Blood; 1999 Aug; 94(3):1086-99. PubMed ID: 10419902
[TBL] [Abstract][Full Text] [Related]
16. [Quantitative analysis of multidrug resistance phenotype in hematological malignancies].
Kobayashi H; Takemura Y
Rinsho Byori; 1998 Apr; 46(4):380-90. PubMed ID: 9594630
[TBL] [Abstract][Full Text] [Related]
17. Quantification of P-glycoprotein in chronic lymphocytic leukemia by flow cytometry.
Maynadié M; Matutes E; Catovsky D
Leuk Res; 1997 Sep; 21(9):825-31. PubMed ID: 9393597
[TBL] [Abstract][Full Text] [Related]
18. Expression of the MDR1 and MDR3 gene products in acute and chronic leukemias.
Arai Y; Masuda M; Sugawara I; Arai T; Motoji T; Tsuruo T; Oshimi K; Mizoguchi H
Leuk Res; 1997 Apr; 21(4):313-9. PubMed ID: 9150348
[TBL] [Abstract][Full Text] [Related]
19. Clinical application of a rapid, functional assay for multidrug resistance based on accumulation of the fluorescent dye, fluo-3.
Wall DM; Sparrow R; Hu XF; Nadalin G; Zalcberg JR; Marschner IC; Van der Weyden M; Parkin JD
Eur J Cancer; 1993; 29A(7):1024-7. PubMed ID: 8098947
[TBL] [Abstract][Full Text] [Related]
20. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype.
Drach D; Zhao S; Drach J; Mahadevia R; Gattringer C; Huber H; Andreeff M
Blood; 1992 Dec; 80(11):2729-34. PubMed ID: 1360266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
